Podcasts about MIPS

Would you rather replace a battery if you can or just get a new thing? Gym replaces a solenoid and Foo cleans up his misters. Foo troubleshoots a starting issue with his motorcycle while Gym has trouble with a battery on a Honda Odyssee. Do you have any weird batteries you have a hard time finding? Gym finally gets his Oakley DT3 helmet in large. Piper graduates and keeps it low-key while turning 21 on the same day. Have you ever been iced? Foo mixes drinks. Gym explains how Rog is doing. Plus more!

Dr. Luis Raez and Michael Reff share the newest update to the medically integrated dispensing pharmacy standards from NCODA and ASCO. They review updates to domain one, on key patient-centered quality standards on health equity and social determinants of health, drug access, patient safety, education, and adherence to maximize treatment outcomes and domain two, on key operational quality standards on logistics, care coordination, and waste prevention. We also cover the impact of these updated standards for clinicians, oncology practices, and people receiving oral anti-cancer medications. Read the complete standards, “Medically Integrated Dispensing Pharmacy: ASCO-NCODA Standards.” Transcript These standards, clinical tools, and resources are available on ASCO.org.  Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the JCO Oncology Practice. Brittany Harvey: Hello, and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts.  My name is Brittany Harvey, and today I'm interviewing Michael Reff from the Network of Collaborative Oncology Development and Advancement and Dr. Luis Raez from Memorial Cancer Institute and Florida Atlantic University, co-chairs on "Medically Integrated Dispensing Pharmacy: American Society of Clinical Oncology – Network of Collaborative Oncology Development and Advancement Association Standards Update." Thank you for being here, Michael and Dr. Raez. Dr. Luis Raez: Thanks for inviting us. Michael Reff: Thank you for having us. Brittany Harvey: Then, before we discuss these standards, I'd like to note that ASCO takes great care in the development of its standards and ensuring that the ASCO Conflict of Interest policy is followed for each guidance product. The disclosures of potential conflicts of interest for the expert panel, including Michael and Dr. Luis Raez who have joined us here today, are available online with the publication of the standards in JCO Oncology Practice, which is linked in the show notes. So then, to dive into the content here, Michael, I'd like to start with what prompted an update to these ASCO-NCODA standards and what is the scope of this update? Michael Reff: Thank you, Brittany. What led NCODA and ASCO to endeavor in this, and it started back in 2019 as the amount of oral anticancer medications became more and more prevalent in cancer treatment, we saw the need providing a blueprint for excellence in care for patients prescribed oral anticancer medications, specifically in the outpatient setting. And the update was driven by the rapid growth of these oral oncolytics starting back in the mid to late 2015 through 2019 or so, and then continued on into the 2020s where we are today. We saw the increase in the complexity of the management of these patients with these therapies basically outside the traditional clinical settings. And we wanted to make sure that with more cancer treatments that are taken at home than just at the clinic, like in the oral setting, new challenges had emerged around patient safety, access, adherence, and overall treatment success. The updates now address patient-centered and operational interventions designed to improve access, safety, quality, accountability, and outcomes of oral anticancer and other supportive care medications prescribed for the cancer patient. Dr. Luis Raez: As Mike said, these guidelines help improve patient care tremendously, but also help us a lot as an oncologist, you know, community oncologists that- now that we have opportunity to dispense these oral oncolytics, we need help to create our medical integrated pharmacies, and NCODA is providing here a way that, how to do this safely, efficaciously, good quality, you know? So that's why I think we always do everything for the patients, but also this helps a lot to the doctors. And there are a lot of what we call specialty pharmacies or medical integrated pharmacies now nationwide. Michael Reff: I'll build on what Dr. Raez had mentioned. This is the impetus. If you looked at the innovation that was coming from the pharmaceutical companies, many of it coming in the oral form for anticancer medications, and based on that, taking a look at the infrastructure that is in place in these practices, whether it's in the community or the IDN or health system settings, this amount of innovation that was coming needed to be addressed by taking a look at the medically integrated oncology team. And these standards address not just the pharmacy component, but also the whole continuum of care, starting with a medical oncologist or the hematologist, with the pharmacists, nurses, the pharmacy technicians, others that are involved in the care of the patient. And there were no standards involved. And when we approached ASCO back in 2018 to eventually publish the first version of these standards, the need was identified, and we worked collaboratively with ASCO to create the first set and then the revisions as we talked about. One thing to note regarding the revision plus the original standards, we had a cross-section of the care team on the committee, and we did that very purposefully. So, the ASCO-NCODA team curated a committee to help develop these original standards and the revision of these standards with medical oncologists both from community and health systems, pharmacists from both community and health systems, and also nurses. And we also included a patient that currently has and currently receives oral anticancer medication. And so NCODA and ASCO are very proud of the committee that we put together because of the experts in their field, but also extended the invitation to a current patient. And we embedded everybody's expertise in the curation of these standards. Brittany Harvey: Absolutely. I appreciate that background and context and how it's critical to improve patient care. And these standards really help oncologists, and we're looking across the continuum of care to provide optimal care for our patients. So then next, Dr. Raez, I'd like to review the key points of the revised standards for our listeners. So for Domain 1, what are the key patient-centered quality standards on health equity and social determinants of health, drug access, patient safety, education, and adherence to maximize treatment outcomes? Dr. Luis Raez: Yeah, this was a great effort, you know, at the multidisciplinary team. And as you can read in the standard, there were more than 240 publications reviewed; more than 55 of them are quoted here. And the standards are in two groups, as you said. With the group one, I'll briefly mention some of them. For example, SDOH, social determinants of health, is very important because as doctors, we prescribe, and sometimes patients don't get the medication, you know? And we prescribe assuming that 100% of the patients will get the medication. But something simple like the patient doesn't have insurance, the patient is underinsured. I have a patient that we didn't have an address to send the medication because he's homeless. Something that as a doctor you say, "Oh, oh my God, this is outside my realm," but it's not outside reality. So that's why, even if we don't think that this is part of our expertise dealing with social determinants of health, the fact that the patients have food insecurity, they don't have transportation, they don't have insurance, they don't have a caregiver, impact tremendously in the outcomes of the therapy. So that's why, basically, in this standard, we want to call attention that SDOH, social determinants of health, needs to be identified. There are in the literature countless examples of why this is important. For example, in the guidelines, we quote two or three examples of prostate cancer studies that, for example, we quote a study of 27,000 people with prostate cancer that were taking oral oncolytics, and how come the fact that the elderly, seniors, the fact that they have high prescription costs, and how all of this affected the adherence to the medication. And that's why it's important to identify the SDOH. And in other sections of the guidelines, we said how to address them, no? Another important thing in this domain is the cultural, you know, we need to be culturally sensitive and to take care of all of these social factors. For example, here in South Florida, we deal with the Haitian culture, Filipino culture, Latin culture, and American culture, and it's a blend, but it's not easy to go from one to the other. Another one is the fact that we have to include new technologies. A lot of patients, for example, we use EMR, EMR Epic, and now Epic has everything in the phone. The fact that we can have now the patient can see her prescription medication over the phone, the fact that they can use the phone to request from you a refill, and from your phone, you send the refill to the pharmacy, and you notify from your phone to the patient that the refill is sent, and the patient can check in his phone that the refill is ready. These things are amazing because that's why it's important that we incorporate these technologies to the patient care, and in this specific case, of dispensation of oral therapies, no? Another crucial point is education. You cannot be sending a patient a package of 300 pills without education. So that's why in our guidelines, mainly pharmacy, clinical pharmacies, or in some centers like mine, we have advanced practice providers, it's mandatory in our centers to have like a one hour of education before you send the prescription. So the patient is aware about side effects and contraindications, all of these things. They provide them also materials and also consent. You know, in the old times, you don't give chemo without a consent. Now, a lot of people say, "Oh, it's only a pill." There is a lot of benefits or side effects that can come from the pill, so you need to consent everybody, you know? So, another aspect is adherence. I already told about that, but we need to provide patients with a baseline assessment, no? So, you cannot send again the prescription and hope, "Oh, I'll figure it out what happened next month when the patient comes back." I tell you, the patient is homeless, where are you going to send it? If the patient is telling you, "I don't have insurance," what good is it for you to send a prescription? The patient will not get it. So that's why you need to do a baseline assessment of adherence. You need to do a calendar. You need to do electronic support, I mentioned already with the EMR and the phones. For example, my MIP, my specialty pharmacist, sends me a message in the EMR, "Dr. Raez, the insurance is not covering, the patient has a high copayment, we are going to delay the dispensation of the medication." So there needs to be a communication. Or sometimes there is a confusion with the insurance, and I cannot wait for the poor patient to call three, four weeks later, "Oh, I didn't get the medication," to know what happened, no? My MIP is very good. They send the clinical pharmacist a message, "Hey, you know, the insurance doesn't believe that the pill is adequate, or you need to provide more documentation. You need to prove the mutation, the genetic aberration." So if you provide us that, the insurance may approve. So that communication with the doctor is very important to improve adherence. And one important thing that we have in this one that we didn't have in the anterior is the tracking of outside medications. A lot of times you say, "Okay, the insurance allowed us to provide the medication it's 100% responsible." But then the insurance says, "Oh, no, no, don't worry. CVS will provide the medication." So it says, "Well, it's you know, it's not my responsibility. CVS will provide the medication, they have to take care." But we know that outside our specialty pharmacies or MIPs, the care is not very good. So that's why we are taking our ownership that, "Okay, the insurance said the patient will get the medication from some outside pharmacy." But our clinical pharmacists track that. What happened? Did the patient get it? The patient didn't get it. The copayment is still high. So even if you get the medication from somewhere else, if the copayment is high, we, our clinical pharmacists, help the patient to navigate and get the foundation or the copayment or finally the maker, the industry partner, provides the drug for free, but somebody needs to do the paperwork. And that's why this is very important. We cannot abort our responsibility because, "Oh, the insurance said somebody else will give it." I work for the public healthcare system, so my patients, some of them don't have insurance, they are underinsured. So we see these problems every day. And finally, the standards talk about the importance of safety, documentation, verification, monitoring, refills, you know, you need to keep track of refills. We already mentioned how important is the technology to facilitate the refills, and the quality. Brittany Harvey: Yes, thank you for touching on those highlights for Domain 1. It's important that all patients have access to care and these oral anticancer medications, and not only just access to care, but safe and effective care. It's really important, as you mentioned, Dr. Raez, to meet patients where they're at and incorporate technology. And I also want to note the coordination with external pharmacies that you mentioned in tracking outside medications as well. It's not only important for multidisciplinary care within the oncology practice itself, but also external to the oncology practice. That's why we put together this multidisciplinary panel to develop these standards. So then, expanding on that, Dr. Raez, for Domain 2, what are the key operational quality standards? Those on logistics, care coordination, and waste prevention. Dr. Luis Raez: Yeah, we have a lot of standards here, but maybe we can summarize in five or six points, no? For example, financial toxicity in cost and waste are very important because the patients, yeah, you put them on therapy, but as you can understand, if there is disease progression, the patient don't need the medications. And sometimes you get refills even if the patient has disease progression. If you do a dose reduction, the same problem. Or you discontinue medication and the patient keeps getting the drugs. So, you're talking about drugs that are between 20 and 30 thousand dollars per month. This is a lot of money. There are studies that we're quoting in the standards that the waste could be from 1 to 3 or 4 thousand per patient, no? Another aspect is dispensing. When you dispense the medication, this is not as easy as, "I'll ship to your house a bag of medications." You know, there needs to be a diagram, a decision tree. You need to train the staff to know what we're doing. There needs to be an auditing of the process. They need to be even packaging and shipping, you know? For example, I'm in Florida today and outside in summer it's going to be 95 degrees. So, everybody leaves the package outside your house, and sometimes you go the whole day until when you come at 6:00 p.m. There are medications that cannot be left outside there, you know? I don't know, it sounds like a joke, but I have a patient that the medication used to be stolen because people thought that that was something important, you know? And of course, it's important because it's a $20,000 medication. So, the poor patient, because he lives in an area that is not safe, has to come and pick up in person. All of these things sound very trivial, but that's real life that affects adherence. Another important thing is shortage. This is something that we just suffered two or three years ago, and we have to think about what happens in the next shortage. What happens if there's going to be a shortage? What do we do or how are we going to do that? Now we know it's something that is happening probably very soon again, and something that we have to consider. Another standard is the care coordination. You need to have probably, if it's possible, a coordinator. I know that for small practices it's very hard, but for big cancer centers, you should have a coordinator of this. I already mentioned before, the communication between the physicians and the doctors to coordinate the care, no? You need to write the prescription again, you need to provide more information, or to be notified, "Hey, you know, the patient is throwing up in the first week, you need to see the patient, please," no? So, this type of communication needs to exist so we can serve the patient better. It's also important, you know, we're improving quality and we're improving care. It's important to try to collect patient-reported outcomes. This is something that now we have the opportunity, if we do things well, to do it and show that we're providing a better care. The other thing is that we already mentioned SDOH in the other standard. In this standard, we mention mainly SDOH to partner. For example, we collect in my center SDOH, and I always get frustrated when the patient doesn't have transportation. But I didn't know that there are local institutions that provide free Uber rides, free Lyft rides. So that's why it's important to partner with these institutions. I have a local grocery chain that provides free food for the patients, and I didn't know that. It's important to be aware what the patient needs and what resources do you have to fulfill the SDOH. That's the part that we mention in here. So that's why, in summary, those are the six probably most important points here. I'll ask Mike for some comments. Michael Reff: Thank you, Dr. Raez. Brittany, to answer your question, and as was pointed out on logistics, care coordination, and prevention of waste, certainly that is an aspect that has changed in the revision that we're here to talk about. There's really two components to waste, and it's cost avoidance and then waste prevention. And as Dr. Raez mentioned several times, the importance of the medically integrated team and having the ability for that practice to fill that prescription internally and have robust documentation. Cost avoidance is a critical component that the medically integrated pharmacy, or the MIP, can help the total cost of care. And that is by preventing errant fills or waste that can occur by intervening in the care of the cancer patient, as we do every day. But when the practice has access to the medication and can fill that prescription in-house in the medically integrated pharmacy, that team, that care coordination that takes place, can prevent those errant fills or additional fills when there's dose reductions, there's holidays, there's things that happen in real time. And it's impossible for a mail-order pharmacy that's in another state that has lead times, when a prescription needs to be mailed 7 days or 10 days before the patient will run out of the medication, it's impossible for them to logistically coordinate that care like we can internally within the medically integrated pharmacy. So, we prevent waste and overall cost of care by cost avoidance and having that coordination or that continuity of care that we talk about. And we prevent waste from the mail-order pharmacies by taking that prescription internally and filling it, but also doing it in a way that's more sustainable and cost-effective for all stakeholders in the oncology ecosystem. Brittany Harvey: Absolutely. Thank you both for reviewing those key standards for Domain 2 and touching on the importance of distribution logistics and all the things that a medically integrated pharmacy needs to think through in getting oral anticancer agents to patients. Following that, Michael, we've touched on this a little bit earlier, but how will these updated standards impact clinicians and oncology practices? Michael Reff: Yes, and as Dr. Raez and I have discussed throughout this podcast, these additional standards are there to help support that continuity of care by educating the clinicians that are in the oral anticancer medication space to elevate their provision for these oral therapies. What I mean by that is the practice has to perform at a certain level in order for them to, as I call it, deserve the right to fill that prescription by having the processes and procedures in place. And these standards, these updated or revised standards, are the blueprint for better patient care and to help the practices execute on that journey of continuous improvement. Dr. Luis Raez: Yeah, I only want to add, we have practical examples in the guidelines. We quote a couple of studies that have been successful. And this year, for example, I am a lung cancer doctor, we are presenting in World Lung our standards of adherence to oral oncolytics for EGFR therapy, following the NCODA-ASCO standards. We're around 95% of adherence. We are a healthcare system that is public. We have people with no insurance and a lot of social determinants of health. We are trying to show that it's feasible, even in the most difficult circumstance, when you follow the standards, to be successful. Brittany Harvey: Definitely, these standards can help clinicians and oncology practices succeed in providing these medications. So then beyond that, and to wrap us up, Michael, what do these revised standards mean for patients who are receiving oral anticancer medications? Michael Reff: Yes, great point and question, Brittany, because we have covered the benefits to the clinicians and the practices themselves. But how is this going to support better patient care? And it does it in a whole host of ways. I'll cover just a few of them. What I'm about to share with you relates back to what we call at NCODA the "core claims." Like, what's the core claims of having a medically integrated pharmacy within the practice? And there are seven different core claims that we feel practices that are focused on the continuity of care can deliver better outcomes that are embedded in these standards. And it's talking about abandonment, adherence, access and affordability, speed to therapy or time to fill, as we call it, education, patient satisfaction, and cost avoidance that we covered earlier. So those are the core claims that a practice that follows these revised standards can help elevate. So, faster and more affordable access to the oral cancer medications; individualized support to address barriers like transportation, finance, language, or health literacy, and so on; clear, patient-friendly education; something that is near and dear to all clinicians' hearts, and of course, the patient that was on our panel or on our committee, to empower them to manage side effects and recognize when to seek help; and a stronger partnership with a care team, with regular follow-ups focused on their experience, challenges, and successes; and then, greater overall safety through proactive monitoring for medication errors or complications. So all of these aspects, or tenets, as I'll call them, are baked into these quality standards that are totally aligned with NCODA's core claims document that, again, talks about abandonment, adherence, access and affordability, speed to therapy, education, satisfaction for the patients, and also cost avoidance. Dr. Luis Raez: I only want to add and invite the community to adhere to these standards, to practice the standards. You will be providing the best patient care that we can nowadays. Brittany Harvey: Definitely. I think these standards are very important. And Michael, I thank you for touching on those key claims from NCODA. I think those, along with these updated standards, will improve outcomes for patients everywhere. So I want to thank you both so much for your work to update these standards and all the time you put into it. And thank you for your time today too, Michael and Dr. Raez. Michael Reff: I'd like to thank not only the committee, my esteemed committee that helped support the standards and the revision. Many of the original healthcare providers and patient that were on the first go of the standards were part of the second standards. We revised it, of course, and we got additional support from the new committee. And certainly ASCO and their partnership and collaboration with NCODA has been tremendous. And we look forward to the oncology community at large adopting these standards, again, to work together, we do become stronger, and it will improve cancer care for patients receiving oral anticancer medications. So thank you, Brittany. Dr. Luis Raez: I only want to say the same thing. Actually, there is probably more people in NCODA that is not in the publication that has helped. Same in ASCO. Also, we want to give thanks to Dr. Stephen Grubbs, our leader in quality. He's retiring. We're going to miss him, but he has been a key collaborator with Mike organizing these standards for the last five or six years. So, looking forward to these standards in practice. Brittany Harvey: Absolutely. A big thank you to the entire panel and everyone who contributed to this, and NCODA as well. And then finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the complete standards, go to www.asco.org/standards. I also encourage you to check out the companion episode on these standards on the PQI podcast by NCODA, which you can find on Apple Podcasts and Spotify. You can also find many of our standards and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

In this follow-up to our last episode on MIPS (Merit-Based Incentive Payment System), Dr. Heather Signorelli takes a deeper dive into what physicians need to know to maximize Medicare reimbursements and avoid penalties. We unpack the four MIPS categories—Quality, Promoting Interoperability, Improvement Activities, and Cost—and how they impact your final score. You'll also hear real-world examples of specialty-specific metrics, tips for leveraging your EMR for MIPS success, and how group vs. individual reporting works. Whether you're new to MIPS or just looking to improve your performance, this episode is packed with actionable insights to help you stay compliant and boost revenue. 

Kevin M. Crawford, MD, FAAD interviewed by Mona Sadeghpour, MD, FAAD

Kraftiga rörelser i en intensiv rapportskörd. Pavel Rosenberg, aktiemäklare på Pareto och Joel Backesten, förvaltare på Danske Bank guidar genom dagens rapportförlorare och fåtalet vinnare. Bolag som avhandlas är bland annat Mips, Husqvarna, Dometic och Beijer Ref.Programledare Elin Wiker och Gabriel Mellqvist.

In this episode, Cherise is joined by returning guest Vladimir Pajkic, Partner from ZGF Architects, a firm with multiple offices across North America and over 750 staff. They discuss the Jen-Hsun Huang and Lori Mills Huang Collaborative Innovation Complex (HCIC) at Oregon State University.You can see the project here as you listen along.At the north edge of Oregon State University's historic campus, a new landmark for innovation is taking shape. The Jen-Hsun Huang and Lori Mills Huang Collaborative Innovation Complex is a 143,000-square-foot facility designed to transform how OSU approaches science, research, and collaboration. The building is also making history as the first all-mass-timber experimental laboratory in the U.S. that meets a demanding 2000 MIPS vibration criterion.If you enjoy this episode, visit arcat.com/podcast for more. If you're a frequent listener of Detailed, you might enjoy similar content at Gābl Media. Mentioned in this episode:ARCATemy

Brandon and Dave talk through the latest news in the NBA during this episode of The NBA Hangout including:Raptors Tank jobAwards games limit ; Is it good ?West Contenders Teams not afraid of OKCPower ranking OKC, Denver, Warriors Memphis overlooked?Cleveland ready?Boston on track for a repeat?Eastern Conference dark horses (Bucks,Knicks & Pacers)MIP candidatesand much much more..Follow us on Twitter/X @TheNBAHangout for updates on the pod as well video highlights and moreFollow us on Twitter: @PlaybookSNFollow us on Instagram: @playbook.sports Hosted on Acast. See acast.com/privacy for more information.

気になる機材の話をするHOT TECH

Quels joueurs ont changé de dimension cette saison ? Avec @LesOUTSIDERZ , on s'est retrouvé pour dresser un top 5 de nos MIPs.

AWadd brings us into The Richmond Commander on the show next as we get his Ten Takeaways from Washington's victory against Tampa Bay. We keep talking about Washington Commanders on the show as AWadd asks the question, what did you learn about this team after their first playoff game. NFL Hits on the show next as we take a look all around the NFL playoffs following a weekend full of blowouts. More Washington Commanders breakdown on the show next as we highlight our defensive and offensive Most Important Players.

Are you ready to lead with clarity and purpose in 2025? Join me on Monday, December 30, at 3 PM ET for a FREE webinar: Take Control of Your Leadership: Clear Priorities, Real Results. In just one hour, you'll learn actionable strategies to define your priorities, recognize and reinforce values, and reclaim your time for the work that truly matters.Save your spot today at www.theprincipalacademy.com/realresults—let's kick off 2025 as your best leadership year yet!Are you feeling overwhelmed and struggling to prioritize your time as a school leader? In this episode, I share some exciting news about my upcoming digital course, Take Control of Your Leadership:. This course is designed to help you overcome overwhelm, focus on what truly matters, and lead with clarity, and it's LIVE - go to theprincipalacademy.com and check out Take Control of Your Leadership.In this engaging conversation, Dr. Darrin Peppard and Barbara Gruener explore the journey of entrepreneurship, the importance of relationships in education, and the therapeutic power of writing. Barbara shares her inspiring background, her transition back to teaching, and the significance of self-care for educators. They also discuss Barbara's latest book, Birdie and Mipps, which reflects on the themes of nicknames and relationships, and the feedback it has received from readers. The conversation concludes with Barbara's insights on leaning into leadership and supporting others in their journeys.TakeawaysEntrepreneurship can lead to meaningful connections.Teaching experiences shape our understanding of education.Relationships are at the core of effective teaching.Self-care is essential for educators to thrive.Writing serves as a therapeutic outlet for emotions.Birdie and Mips explores the significance of nicknames.Feedback from readers can highlight the impact of a book.Mentorship plays a crucial role in leadership.Inspiration and kindness can transform lives.Everyone is fighting their own battles, and empathy is key.Find Barbara at:corneroncharacter.combarbaragruenerauthor.com

Send us a textNews1. Vail Resorts Expands in the Alps2. Les Deux Alpes Unveils the Jandri 3S Lift3. Breckenridge Sets Shot Ski World Record4. Hokkaido's Kamui Ski Links Transformation5. "Norfolk Alps" Mistake in Netflix Series7. Jeep Driver Gets Stuck on Northstar SlopesWhere's Best to Ski Now?1. Europe: Exceptional Early Season ConditionsAlps: Incredible snowfall in France, Switzerland, Austria, and Italy.Major resorts are open, with more terrain becoming accessible weekly.Key spots:France: Tignes, Val Thorens (115cm at the summit), Alpe d'Huez.Austria: Mayrhofen (80% terrain open, 120km of slopes).Switzerland: Zermatt (100km of runs).Italy: Val Gardena (150km open).Upcoming storms to bring 40-120cm of snow across the northern Alps by the weekend, benefiting resorts like Avoriaz, Verbier, and St. Anton.Pyrenees: Significant improvement after slow start.La Mongie (France): Over 1m of snow at resort level.Baqueira Beret (Spain): Excellent conditions after heavy snowfall.2. North America: Heavy Snowfalls Across Key StatesCalifornia: Lake Tahoe and Mammoth Mountain report bases of 50-85 inches.Wyoming: Jackson Hole received 3 feet of snow in 3 days.Colorado, Utah, Montana: Exceptional snow depth and coverage across major resorts.Avalanche Warnings: Elevated risk in Idaho, Wyoming, and Montana; exercise caution off-piste.Helmet Round-Up Summary1. Salomon Brigade Index HelmetPrice: £100-£130.Best For: Budget-friendly, eco-conscious skiers prioritizing safety.2. Oakley MOD BC HelmetPrice: £200-£250.Best For: High-performance skiers seeking premium features and sleek design.3. Bolle X-Fusion Pure Visor HelmetPrice: £260+ (up to £400 with add-ons).Best For: Skiers preferring a visor helmet with sustainability in mind.4. Head Cinema Pro W Visor HelmetPrice: £120.Best For: Women seeking stylish, versatile visor helmets at a great price.5. Smith Nexus MIPS HelmetPrice: £240.Best For: Tech-savvy skiers who value safety, comfort, and music compatibility.6. Sweet Protection Trooper 2Vi® Mips HelmetPrice: £250-£300.Best For: Freeriders needing top-tier protection and performance.Key Takeaways: Whether you're after eco-conscious gear, visor helmets, or high-tech features like MIPS, there's a helmet for every skier. Prioritize your needs—be it safety, style, or sustainability—and hit the slopes with confidence!And finally we explored to resort of Cape Smokey - Nova Scotia with Martin In the meantime Enjoy the mountains :) And Please do leave a review as it's the only way other like minded travellers get to find us! And don't forget to check us out on the following channels inthesnow.cominstagram.com/inthesnowTikTok@inthesnowmag youtube.com/inthesnowmagfacebook.com/inthesnowTo contact us with your suggestions for further episodes at dom@InTheSnow.com / robert@ski-press.com

Send us a textIn this weeks episode Dom and Rob talk to Eddie the Eagle on how to get into ski jumping.News:Carv 2 LaunchesCarv 2, the advanced ski tech, has launched with major upgrades. The new system clips onto your ski boot strap, replacing the old inserts, and features a more accurate algorithm for tailored feedback based on snow conditions and terrain. Rob tested it in Austria and praised its flexibility, real-time coaching, and data tracking. For more, visit getcarv.com.Lenzerheide's New CampaignLenzerheide, a Swiss ski resort, launched its World of Wonders (W.O.W.) campaign with a video featuring skiers Nico Vuignier and Didier Cuche. The resort is known for its versatile offerings and major events like the UCI Mountain Bike World Cup. It will host the 2025 Biathlon World Championships. Watch the DREAMLINE video.The Great British Ski Test 2024The Great British Ski Test takes place from March 9th-15th, 2024, offering skiing, ski tests, lessons, and social events. Packages start at £1,550. For more info or bookings, contact Carole at carole@pilaski.co.uk.Mia Brookes Wins Big AirMia Brookes, 17, won the FIS Snowboard World Cup Big Air contest in China with a cab 1440 stalefish, scoring 179.75 points. Japan's Mari Fukada and Anna Gasser placed second and third.They talk avalanche safety and also introduce GoMiloby - a travel company specializing in the French Pyrenees, offering affordable, hassle-free holiday packages. They focus on providing great value by cutting out the middleman, with options for solo travelers, couples, or families. Miloby offers two main accommodations: scenic, south-west facing cabins with stunning views and sunsets, located 650 meters above sea level, and a newly renovated hotel set to open in February 2025 with luxurious studios and apartments. The cabins are secluded yet easily accessible, only 20 minutes from the Saint Lary ski resort and 25 minutes from Loudenvielle. Miloby also runs a ski school, creating complete packages for guests. The resort is known for its modern ski infrastructure, low crowds, and affordable dining options. Transfers from Lourdes and Toulouse airports are quick and convenient, making it an ideal spot for a winter getaway. For more, visit gomiloby.com..Gear:SCOTT Flow Pro MIPS Helmet (£180) A high-performance freeride helmet with MIPS® for added safety, RECCO® for avalanche rescue, and eco-friendly features like 98% recycled PC. It includes adjustable ventilation for temperature regulation. Weight: 500g. Watch on YouTube.SCOTT Vest Airflow W's Back Protector (£140) Highly ventilated for comfort during rigorous runs, with a simple adjustable waist-belt for ease. A stylish alternative to traditional black.Fischer RC4 Pro MV BOA DYN Boots (£700) A high-end freeride boot with BOA® Fit System for a micro-adjustable fit and a Dynafit® insert for uphill and downhIn the meantime Enjoy the mountains :) And Please do leave a review as it's the only way other like minded travellers get to find us! And don't forget to check us out on the following channels inthesnow.cominstagram.com/inthesnowTikTok@inthesnowmag youtube.com/inthesnowmagfacebook.com/inthesnowTo contact us with your suggestions for further episodes at dom@InTheSnow.com / robert@ski-press.com

Brandon and Dave talk through the last week in the NBA on this episode of The NBA Hangout including:Recap of the NBA Cup Group StageBreakdown of NBA Cup Knockout round matchupsNBA Cup PredictionsMost Improved Players (All Star Jumps & Wildcards)and much much more....Follow us on Twitter/X @TheNBAHangout for updates on the pod as well video highlights and moreFollow us on Twitter: @PlaybookSNFollow us on Instagram: @playbook.sportsVisit our website www.playbooksn.com for all podcasts, articles, and future bets Hosted on Acast. See acast.com/privacy for more information.

Web: www.JonesHealthLaw.com Phone: (305)877-5054 Instagram: @JonesHealthLaw Facebook: @JonesHealthLaw YouTube: @JonesHealthLaw The Merit-Based Incentive Payment System (“MIPS”) established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), came into effect on January 1, 2017. The MIPS program was designed to adjust Medicare payments based on clinical performance. MIPS only applies to eligible professionals whose practice caters to Medicare Part B beneficiaries. MIPS evaluates the clinical performance of eligible professionals using a composite performance score, comparing performance on a measure to measure benchmark. The results indicate whether the eligible professional will receive a decrease, an increase, or the same Medicare reimbursement for Part B claims. --- Support this podcast: https://podcasters.spotify.com/pod/show/joneshealthlaw/support

  In this episode, we dive into the world of MIPS (Merit-Based Incentive Payment System) and its impact on healthcare providers. Hosted by Morgan Knight, Channel Manager for DrChrono by EverHealth, this conversation features Maura Flaherty, Partnership Sales Consultant, and Debbie Belczyk, Account Manager, from Healthmonix.  We explore the essentials of the MIPS program, its evolution, and the key challenges providers face. You'll hear insights on how Healthmonix's MIPS solutions seamlessly integrate with DrChrono's EHR platform and simplify the reporting process to improve practice financial outcomes. The discussion also touches on trends in value-based care, and upcoming changes in MIPS reporting – check out the webinar hosted by Healthmonix to learn more about the 2025 PFS Final Rule (*linked below).  Learn how the unique partnership between DrChrono and Healthmonix is empowering practices to comply with federal requirements, improve care quality, and maximize your practice's financial incentives. Whether you're new to MIPS or looking to optimize your reporting, this episode offers valuable takeaways for every provider.  Resources:  DrChrono by EverHealth Marketplace: MIPSPro  Quality Payment Program Website  Healthmonix Webinar: 2025 PFS Final Rule  2025 Medicare Physician Fee Schedule (PFS) Final Rule 

In the fourth of this winter's equipment specials, Iain is joined by Al Morgan to look at two really important areas of your winter wardrobe – helmets and goggles.  Previous episodes in this series have included the Best Skis, Best Ski Boots and Best Ski Jackets for winter 2025.   This Special Episode of The Ski Podcast has been made possible by Ellis Brigham. They are the winter sports specialists, with 16 shops around the UK where you can find all the kit you need for this winter. Alternatively, simply go to their website at ellis-brigham.com where you can buy online now.' SHOW NOTES ‘Fit is King'  Safety Standards (6:00)  ‘Multi norm' helmets (6:30)   EPS foam (8:45)  MIPS (9:30)  Fidlock buckle (11:45)  Venting (12:00)  Visor Helmets (14:15)  Sustainability features (16:00)  UV Protection (28:45)  Fogging (29:45)  How to use a lens cloth (30:45)  When to change your lens (32:30)  Photochromic lenses (33:45)  Colour handling (34:30) The Best Ski and Snowboard Helmets for 2025  ·       Giro Tor Spherical Helmet, £250 (17:45) ·       Atomic Savor Visor Helmet, £180 (19:15) ·       Bern Watts 2.0 MIPS, £160 (21:15) ·       Salomon Brigade Index Helmet, £110 (23:15) ·       Oakley Mod1 Helmet, £85 (24:30)   ELLIS BRIGHAM'S CHOICE (26:30) Chrissy from Ellis Brigham in Braehead Garden chose the Smith Method Pro MIPS helmet  The Best Ski and Snowboard Goggles for 2025 ·       Julbo Launcher Reactiv, £280 (36:30)  ·       Oakley Line Miner Pro, £259 (39:30) ·       100% Snowcraft, £179 (41:30) ·       Smith Squad S, £125 (42:45) ·       Bloc Boa Recycle, £48 (44:30) ELLIS BRIGHAM'S CHOICE (45:30) Chrissy from Ellis Brigham in Braehead chose the Dragon DX3 Plus  Feedback (48:15) Please contact us on social @theskipodcast or by email theskipodcast@gmail.com   James Rice: "Just listened to the Ski Boot episode: excellent, as always. Keep up the great work" Colin: "I got all excited after the ski boot episode and bought my first pair of ski boots: a pair Nordica Speedmachine 3s" David Faller: "Enjoyed Episode 219 about the history of Ellis Brigham"  Andrew Greenwood: "Great show guys, very informative about Ski jackets" Try the Picture Organic Naikoon for as a men's version of the Haakon Stephen Street: “I can't believe that the subject of ‘pit zips' were not brought up in the description of these jackets! They are one of the most important ways of controlling heat!”   If you like the podcast, there are two things you can do to help:   1) Review us on Apple Podcasts or Spotify – helps listeners find us 2) Subscribe, so you never miss an episode 3) Listen to our back catalog, just go to theskipodcast.com and search around the tags and categories: you're bound to find something of interest to you You can also view these equipment specials on the Skipedia YouTube channel   You can follow Iain @skipedia and the podcast @theskipodcast

AWadd on The Richmond Commander on a Jayden Daniels appreciation day as well as MIPS day as Adam picks the most important Washington Commanders as we head into a battle against Carolina. NFL Hits on the show as we take a peek at the week 7 NFL slate and give out our picks for the 1, 2, and 3 star games of the week as well as the dud game of the week. Behind Enemy Lines on the show next as we are joined by Carolina reporter Dennis Cox. Dude Food next as we talk about new fast food items and we start to get excited about a Thanksgiving dinner.

To kick off the Best Of, Crosstalk with Michael Phillips on the show as we talk all things Jayden Daniels as he leads the future of the franchise. AWadd on The Richmond Commander on a Jayden Daniels appreciation day as well as MIPS day as Adam picks the most important Washington Commanders as we head into a battle against Carolina. Behind Enemy Lines on the show next as we are joined by Carolina reporter Dennis Cox. Moneyline Mac on the show next as we go all around College Football for week 8 and make bets across all the best games.

AUDIO THIS WEEK HAD A SAMPLE RATE ISSUE. SORRY FOR IN INCONVENIENCE. -- During The Show -- 00:52 Steve's WiFi We think its fixed! Noah brought lots of gear Replaced some hardware 02:41 Recovery after power surge - David Cattle not Pets Steve's Nextcloud experience Noah's laptop approach 09:43 Communications App Upheaval - Charlie There is a war on encrypted messaging Courts are making decisions 12:45 Listener Responses To Listener (cameras in home) - Chris UniFi Wave Pico system 13:51 News Wire AlmaLinux Certification SIG - almalinux.org (https://almalinux.org/blog/2024-09-10-announcing-new-certification-sig/) Wine 9.17 - gitlab.winehq.org (https://gitlab.winehq.org/wine/wine/-/releases/wine-9.17) Samba 4.21 - samba.org (https://www.samba.org/samba/history/samba-4.21.0.html) Rust 1.81 - blog.rust-lang.org (https://blog.rust-lang.org/2024/09/05/Rust-1.81.0.html) GNU Nano 8.2 - lists.gnu.org (https://lists.gnu.org/archive/html/info-gnu/2024-09/msg00001.html) Firefox 130 - mozilla.org (https://www.mozilla.org/en-US/firefox/130.0/releasenotes/) QEMU 9.1 - qemu.org (https://www.qemu.org/2024/09/03/qemu-9-1-0/) Peropesis 2.7 - peropesis.org (https://peropesis.org) RLXOS 2.0 - rlxos.dev (https://blog.rlxos.dev/introducing-rlxos-20-sankalpa) Q4OS Released - q4os.org (https://q4os.org/blog.html) Rust Kernel Support for MIPS - phoronix.com (https://www.phoronix.com/news/Rust-Linux-Kernel-MIPS-Patches) Linux in Automotive - globenewswire.com (https://www.globenewswire.com/news-release/2024/09/10/2943456/0/en/Eclipse-Foundation-Releases-Landmark-Report-on-Open-Source-Software-in-Automotive-Design.html) MX Linux 23.4 - mxlinux.org (https://mxlinux.org/blog/mx-23-4-libretto-now-available/) Tails 6.7 - torproject.org (https://blog.torproject.org/new-release-tails-67/) EasyOS 6.3 - bkhome.org (https://www.bkhome.org/news/202409/easyos-scarthgap-series-version-63-released.html) Virtualbox 7.1 - virtualbox.org (https://www.virtualbox.org/wiki/Changelog-7.1) KDE 6.2 - kde.org (https://kde.org/announcements/plasma/6/6.1.90/) KDE Frameworks 6.6 - kde.org (https://kde.org/announcements/frameworks/6/6.6.0/) Shotcut 24.09 - shotcut.com (https://shotcut.com/blog/new-release-240913/) Ardour 8.7 - ardour.org (https://ardour.org/whatsnew.html) White House Working Group - govciomedia.com (https://govciomedia.com/feds-prioritize-open-source-software-security-initiatives/) Tidelift Study - businesswire.com (https://www.businesswire.com/news/home/20240917030299/en/Tidelift-Study-Reveals-Paid-Open-Source-Maintainers-Do-Significantly-More-Critical-Security-and-Maintenance-Work-Than-Unpaid-Maintainers) OpenSearch Foundation - techcrunch (https://techcrunch.com/2024/09/16/aws-brings-opensearch-under-the-linux-foundation-umbrella/) Hedera - cointelegraph.com (https://cointelegraph.com/news/hedera-linux-foundation-hiero-decentralized-trust) Linux 6.11 - phoronix.com (https://www.phoronix.com/news/Linux-6.11) MNT Reform Next - arstechnica.com (https://arstechnica.com/gadgets/2024/09/all-open-source-mnt-reform-laptop-is-getting-a-sequel-with-a-refined-design/) Juno Tab 3 - colocrossing.com (https://www.colocrossing.com/blog/introducing-the-juno-tab-3-a-699-linux-tablet-equipped-with-ubuntu-24-04-lts/) Oracle Weblogic Exploited - thehackernews.com (https://thehackernews.com/2024/09/new-linux-malware-campaign-exploits.html) Advanced materials AI Model - aibusiness.com (https://aibusiness.com/nlp/new-open-source-ai-model-for-advanced-material-design-unveiled) LightEval - venturebeat.com (https://venturebeat.com/ai/lighteval-hugging-faces-open-source-solution-to-ais-accountability-problem/) RHEL AI - businesswire.com (https://www.businesswire.com/news/home/20240905544240/en/Red-Hat-Enterprise-Linux-AI-Now-Generally-Available-for-Enterprise-AI-Innovation-in-Production) 17:55 Immich Developer scratches his own itch Immich better than google photos now Google data pull GitHub Script (https://gist.github.com/chabala/22ed01d7acf9ee0de9e3d867133f83fb) * 7z x *.zip Roadmap Private/Locked photos In app editing Auto stacking Funding Foodo Steve's current photo solution Immich backup methods Forground Background Manual sync button Sharing/Collaboration Infinite scrolling Social aspect Deletion issue Requires inputting the port 37:00 FCC and 900Mhz Meshtastic LoRa Chirp Spread Spectrum Only good for long range small packets of data Rx/Tx Wattage NextNav wants to buy the spectrum LoRa enables lots of possibilities Lilygo T Deck Plus (https://www.lilygo.cc/products/t-deck-plus) Rokland blog post (https://store.rokland.com/blogs/news/help-us-protect-meshtastic) Licensing the frequency stifles innovation Could hamper emergency response Having open frequencies democratizes communication LoRa FCC Guide (https://www.sunfiretesting.com/LoRa-FCC-Certification-Guide/) Opposition_Letter (https://cdn.shopify.com/s/files/1/0071/3772/files/Opposition_Letter.pdf?v=1725463027) FCC Paths to LoRa Certification FCC Part 15.247 - Digital Modulation FCC Part 15.247 - Frequency Hopping Spread-Spectrum (FHSS) FCC Part 15.249 - All Other Transmission in the 900MHz range FCC Part 15.247(b)(3) Problematic spectrum impact -- The Extra Credit Section -- For links to the articles and material referenced in this week's episode check out this week's page from our podcast dashboard! This Episode's Podcast Dashboard (http://podcast.asknoahshow.com/407) Phone Systems for Ask Noah provided by Voxtelesys (http://www.voxtelesys.com/asknoah) Join us in our dedicated chatroom #GeekLab:linuxdelta.com on Matrix (https://element.linuxdelta.com/#/room/#geeklab:linuxdelta.com) -- Stay In Touch -- Find all the resources for this show on the Ask Noah Dashboard Ask Noah Dashboard (http://www.asknoahshow.com) Need more help than a radio show can offer? Altispeed provides commercial IT services and they're excited to offer you a great deal for listening to the Ask Noah Show. Call today and ask about the discount for listeners of the Ask Noah Show! Altispeed Technologies (http://www.altispeed.com/) Contact Noah live [at] asknoahshow.com -- Twitter -- Noah - Kernellinux (https://twitter.com/kernellinux) Ask Noah Show (https://twitter.com/asknoahshow) Altispeed Technologies (https://twitter.com/altispeed) • Ask Noah Show © CC-BY-ND 2021 •

I Börspanelens avsnitt 26 kommenterar Marcus Hernhag, Arne Kavastu Talving, Lars-Erik Boström och Jan Sterner senaste kvartalsrapporterna och vaskar fram vinnarna. Resten av börsåret fortsätter i positiv anda enligt panelen.Aktierna och fonderna vi säger något om är Atlas Copco, ABB, Alfa Laval, Sandvik, Veteranpoolen, Astra Zeneca, EQT, Nordnet, Avanza, AAK, Raysearch, Bahnhof, Bredband2, Veteranpoolen, Gränges, Addtech, Indutrade, Volvo, Evolution, VBG, Munters, Mips, Ambea, Biotage, Nokia, XACT Småbolag, Fortnox och Lundin Mining. Börspanelens alla sajter hittar du här:shows.acast.com/tresmarta/aboutHernhag.seBorspsykologen.seSternersforlag.se Hosted on Acast. See acast.com/privacy for more information.

All three sibs are back to talk about The Bear season finale and next season predictions. We also chat about season MVPs, MIPs (most improved) and that restaurant review cliffhanger. We finish the ep by quickly discussing the latest from Presumed Innocent and The Boys, which definitely got our attention. Sign up for the Friday Night Movie Newsletter for giveaways, curated episode playlists from the hosts and guests (including our mom), and at MOST one email per month (and probably fewer).  Closed captions for this episode are available via the player on the official Friday Night Movie homepage, the Podbean app and website, and YouTube.  The Friday Night Movie Family supports the following organizations: The Red Tent Fund | HIAS | Equal Justice Initiative | Asian American Journalists Association | The Entertainment Community Fund. Subscribe, rate and review us on your favorite podcast platform, including iTunes | Spotify | Stitcher | Google Play | Podbean | Overcast. Play along with Friday Night Movie at home! Read the FNM Glossary to learn the about our signature bits (e.g., Buy/Rent/Meh, I Told You Shows, Tradesies, etc). Email us at info@p4tmedia.com or tweet @FriNightMovie, @pancake4table, @chichiKgomez, and/or  @paperBKprincess.  Follow our creations and zany Instagram stories @frinightmovie, @FNMsisters, and @pancake4table. Follow us on Letterboxd (@pancake4table) where we're rating every movie we've EVER watched.  Subscribe to our quarterly newsletter for exclusive giveaways and news! Theme music by What Does It Eat.  Subscribe and leave a review on IOS or Android at frinightmovie.com.

Host Justin Barnes, aka the @HITAdvisor, invites back health care policy expert Greg Fulton to discuss the critical challenges and strategic solutions that are shaping the future of healthcare. Hear how value-based care levers and MIPS quality reporting can transform your care strategy. Gain insights and actionable strategies to enhance care coordination and capitalize on financial incentives. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In Episode 468 seht ihr den Test eines neuen Bionicon Wyatt Trail 625 1 mit Bosch-CX-Motor und wir stellen euch den neuen Mavic Deemax Mips MTB-Helm vor. Das gewohnte Gewinnspiel wartet ebenfalls.

Sylvia Parra, MD interviewed by Hillary Johnson-Jahangir, MD, PhD FAAD

Max Strandwitz, CEO of MIPS Protection shares the vision for sustainability and core values of his team, a leader in the field of brain protection systems within helmet-based safety manufacturing for over 25 years. The mission at MIPS is to reduce head injuries, save more lives, protecting people and the environment.  Max became CEO in 2019 bringing a long career in finance from the fast-moving consumer goods sector and now leads the sustainable design and manufacture of a range of products that are sustainable, enduring and fit for purpose. MIPS have stepped up on their sustainability commitments to protect people and the environment. Join here to hear why MIPS care, dare, and want to share their efforts centred around their employees, products, and their supply chain.

Over the course of his fascinating career, Mark Himelstein has worked on several significant computing technologies at historic companies like MIPS and Sun Microsystems. He has also worked as a consultant in various roles that include architect, VP of engineering, and advisor. However, RISC-V may have a greater impact on the computing field and our world than any of those previous efforts.  Himelstein gives us an insiders view on the open standard process that is often “cooperation and competition, simultaneously.” “The thing that keeps us as a community is the effort in the software ecosystem. Nobody wants to really go off and go on their own. They just don't want to do it. It's just too costly. I don't care if you're the biggest company in the world or the tiniest.”  Listen in on this episode of the Moore's Lobby podcast as Daniel Bogdanoff and Himelstein chat about a wide range of interesting topics that include: -How Himelstein encourages people to get involved with RISC-V by telling them to not just complain about something, but join in to help make it better. -The significance of vector operations for computing and how those advantages may soon be extended to matrix operations within the ISA. -Three major things RISC-V is currently working on for future release.  

Esfandiar Baraheni returns to discuss his article in Forbes calling for the NBA to debut five man teams for the Most Improved Player award. Then, he runs down his MIP winner, honorable mentions, and three five man units for 2024. We dive into the philosophy and importance of improvement, how the draft can predict it, which improvements matter the most, and what they say about where the league is going. Enjoy!0:00 Intro + MIP Race and Maxey14:40 First Team with Coby, Jalen Johnson, Sengun, Kuminga, JDub40:00 Second Team with Herb Jones, Derrick White, Suggs, Deni, Sexton53:40 Third Team with RJ Barrett, Vince Williams Jr., Nesmith, Strus, Watson

Today we're discussing current helmet technology, head injuries, and best practices for skiers & snowboarders with Blister reviewer (and physician assistant), Sascha Anastas; Sr. Director of R&D at Giro, Steven Kennedy; the CMO of MIPS, Frederik Kjellberg; and pro skier, Drew Petersen.RELATED LINKS:Blister Recommended Shop: Boone Mtn SportsGet Covered: BLISTER+VIDEOS: Blister YouTube ChannelTOPICS & TIMES:MIPS Backstory & Purpose (4:28)Skull Fractures & Concussions (9:10)Helmet R&D & Various Testing Standards (14:50)Athlete Perspective on Helmet Testing (19:56)Advice for Buying Helmets (25:02)Different Versions of MIPS (28:06)Drew's Take: Choosing Helmets (30:36)Replacing Helmets: When & Why? (32:00)Audience: Mental Side of Accidents (35:02)Audience: Concussions & Long-Term Effects (42:57)Audience: Helmet Replacement Cont. (44:28)Closing Thoughts (46:20)CHECK OUT OUR OTHER PODCASTS:Blister CinematicCRAFTEDBikes & Big IdeasBlister PodcastOff The Couch Hosted on Acast. See acast.com/privacy for more information.

March 1, 2024Hosts Scott, Mark, and Ray discuss the upcoming MIPS submission deadline of April 1st and address common questions about MIPS submissions. Registration is open for the Documentation for Coding and Reimbursement for APPs Course - Starts 3/11/24Click Here for Information and to JoinPRS Billing and Other ServicesClick Here to Get More Information and Request a Quote   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/    Join the discussion:Urology Coding and Reimbursement Group - Join for free and ask your questions, and share your wisdom.Click Here to Start Your Free Trial of AUACodingToday.com

The Merit-based Incentive Payment System (MIPS) uses a composite performance score to determine if eligible physicians will receive a payment bonus, a payment penalty, or no payment adjustments. So, what's the score for your physicians? Do they know?During the next live edition of the long-running Monitor Mondays, Leigh Poland, vice president of coding services for AGS Health, will report on why it's essential for all eligible clinicians to report their score to prevent a 9-percent downward adjustment for all Medicare Part B claims paid two years from the reporting year.Broadcast segments will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Kate Brantley, state legislative analyst for Zelis, will report on current healthcare legislation.• Lead Story: Leigh Poland, vice president of coding for AGS Health, will report on the importance of physicians reporting their MIPS scores.

Welcome to MattPAC*, a new Accelerators pilot concept!Radiation Oncologist Dr. Matt Spraker aims to introduce important healthcare policy concepts rooted in current events. Each show is designed to be efficient with your time and inspire you to get engaged with advocacy in around 30 minutes. In MattPAC #1, Matt covers quality payment programs (QPP). QPPs aim to incentivize "High Quality Care" by adjusting a portion of physician's pay according to performance on quality indicators, measures of healthcare quality. We'll discuss the rich history of care quality improvement in radiation medicine and examine how Medicare has approached the QPP with Merit-based Incentive Payment System (MIPS). After, we examine practice accreditation, the QPP approach proposed in ASTRO's ROCR and close with a brainstorm of a better QPP. Here are some good resources for further reading on these topics:Albert and Das reviews, Quality Assessment in Oncology and Quality Indicators in Radiation OncologyMedPAC report, Examining MACRA implementation and the road aheadMedPAC report, Moving beyond the MIPsGAO Report, Provider Performance and Experiences under the Merit-based Incentive Payment SystemPatel et al., Oncologist Participation and Performance in the Merit-Based Incentive Payment SystemLuh, Radiation Oncology Alternative Payment Model's Impact on Small and Rural PracticesJones et al., Merit-Based Incentive Payment System (MIPS) Participation in Radiation Oncology Practices — A Simple SurveyChera et al., Improving Quality of Patient Care by Improving Daily Practice of Radiation OncologyCoia and Hanks, Quality Assessment in the USA: How the Patterns of Care Study Has Made a Difference Hanks et al., Patters of Care Studies: Past, Present, and FutureVisit the CMS QPP page for a lot of info: check your participation status, MIPs guides, APMs, and moreASTRO ROCR FAQ pageThe Accelerators Podcast is a production of Photon Media, a division of Cold Light Legacy Company.*MattPAC is not a political action committee, it's just a cute name. If you'd like to support our efforts, please visit the Cold Light Legacy Company to learn more.

In this episode, we talk quality with Dr. Arjun Venkatesh. Specifically, we talk about the E-Qual program and how it plays an integral role with the return of MIPS and the development of patient and physician oriented metrics. To learn more about E-QUAL: https://www.acep.org/administration/quality/equal/emergency-quality-network-e-qual/ To check out our new podcast, Qual-ED: https://soundcloud.com/qual-ed Reach out to the E-QUAL team at EQUAL@acep.org

Iain and Al cover the best new ski helmets and goggles for winter 2024, plus we explain all the jargon, including MIPS This Special Episode of The Ski Podcast has been made possible by Ellis Brigham - the winter sports specialists.   They have 16 shops around the UK where you can find all the kit you need for this winter. Alternatively, simply go to their website at ellis-brigham.com to buy online now. SHOW NOTES Catch up with our previous episodes on the best skis, ski boots and ski jackets  Helmet terminology:  ‘Fit is king' (2:15) Safety Standards (3:00) What do EPS and MIPS stand for? (4:00) The importance of the strap (5:45) Passive v. active (adjustable) venting (6:00) Visor Helmets (7:00) The Spektrum Brunner helmet may be the greenest ever (8:45) What is the natural life of a ski helmet? (17:00) The Best Ski & Snowboard Helmets for Winter 2024 Sweet Protection Grimnir 2VI MIPS, £410 (10:00) This is expensive but beautifully made. The shell is made using pre-preg carbon fibre for incredible strength to weight, ten vents with grill covers and their own MIPS 2VI system. This is available in other Sweet helmets, including the £230 Sweet Ingiter. Visit the Sweet Protection website to learn more.   Giro Tor Spherical, £250 (11:45) A very comfortable helmet that uses the MIPS Spherical system with a hybrid construction of hard-shell upper and in-mold lower. It has adjustable venting, a dial fit system, Fidlock magnetic buckle, Recco reflector.   Head Rachel and Head Radar – £200 (12:45) A light, visor helmet with great functionality to fit with prescription glasses or lens can be removed. Uses Head's Sphere Fit BOA system to adjust fit, adjustable venting, and excellent lens. Note that if you wear with goggles and no visor, there's not goggle retainer. The Rev and Rita models are sold without the visor.    Salomon MTN Lab – £155 (14:00) A multi-purpose light (400g) helmet certified for climbing and skiing, so a superb choice for ski tourers. Passive venting, dial-fit system, removeable washable Merino liner, separate summer liner, head-torch clips and an elasticated goggle retainer at the rear. It uses Salomon's EPS 4D liner, so the EPS core of the helmet provides crumple-zone like features, making it 30% safety than the European standard.    Oakley MOD 1 – £85 (16:00) A super-clean skater-inspired design. Light, BOA fit, washable liner and ear pads and available in a massive range of colours. If you want this style but with a brim or peak, the dual cert (ski and bike) hard shell Smith Holt at £80 is an excellent choice, at around 150g heavier. Goggle Terminology:  UV protection (18:30) What is VLT? (19:45) When to change the lens (21:00) How to clean the lens in goggles (23:00) Cylindrical, spherical or toric lenses (24:30) The Best Ski & Snowboard Goggles of Winter 2024 Smith 4D Mag - £320 (24:00) Uses their ChromaPop lens, with magnetic lens swap feature from the S3 ChromaPop Sun Red Mirror and S1 ChromaPop Storm Yellow Flash low light lens. Comes with a zippered hard case, lens and a microfibre bag.   Dragon PXV Dennis Ranalter Signature Goggle– £165 (26:00) The Lumalens Dark Smoke has a 23% VLT (S2) Toric lens, which works well for sunny days and when the clouds arrive. Comes with an extra Lumens Light Rose lens with 66% VLT. Oakley Line Miner – £138 (27:15) A medium fit product, also available in a Line Miner Large version. Available in a large range of frame and lens colour options, but the Prizm Saphire Iridium lens (Cat S3 13% VLT) is a stand-out. Silicon lined strap, triple layer face foam, microfibre bag and notches in the frame allow them to work over the legs of prescription glasses.   Bloc Boa – £45 (29:15) The standard black has a Cat S2 spherical lens (19% VLT) and a silver mirror finish. For the price, with a UV400 lens, anti-fog coating, triple layer face foam and silicon lined strap, microfibre bag this is excellent value. Feedback I enjoy all feedback about the show,so please contact us on social @theskipodcast or by email theskipodcast@gmail.com   If you like the podcast, there are two things you can do to help:  1) Review us on Apple Podcasts or Spotify  2) Subscribe, so you never miss an episode    You can follow me @skipedia and the podcast @theskipodcast and find all our back episodes at www.theskipodcast.com 

Free, ungated access to all 290+ episodes of “It's 5:05!” on your favorite podcast platforms: https://bit.ly/505-updates. You're welcome to

Join us as we demystify the Merit-based Incentive Payment System, offering valuable insights and tips to help healthcare professionals optimize performance, enhance patient care, and navigate the complex landscape of quality reporting.  Check out this week's podcast to dive into the world of MIPS with expert guidance to ensure your practice thrives in the ever-evolving healthcare landscape.Join other healthcare professionals in the discussion on Facebook Group RevMD.Don't miss an episode, subscribe via Apple Podcasts and if you haven't done so already, Leave us a review on Apple Podcasts.If you are looking for a reliable, data-driven, medical biller to help grow your revenue reach out to Info@nationalrevenueconsulting.com or visit us here.

Mips AB (publ), Q3 2023 Earnings Call, Oct 26, 2023

0:00 -- Intro.1:27 -- About this podcast's sponsor: The American College of Governance Counsel.2:23 -- Intro of Webinar (and speakers) by Nancy Easterbrook, Executive Director of SVDX.5:33 -- Start of webinar by Dan Siciliano, Chair of SVDX.6:40 -- Some differences between private (VC-backed) and public boards.9:23 -- The role of independent directors in venture-backed companies. 14:00 -- Specific issues in VC industry: preferred vs common shares and impact on director fiduciary duties and dual-fiduciary duties. The Trados case (2013).18:14 -- An edge-case proposed by Heidi Roizen: voting as a director vs voting as a shareholder. The "sanctity of the preference stack" vs management carve-out.23:44 -- How "bad" directors can negatively impact companies and the proper use of special independent committees to "cleanse transactions." The role company counsel. Funding managing incentive plans (MIPs).29:39 -- Two lessons for independent directors from Heidi Roizen: 1) "avoid messing with waterfall distributions" and 2) run a thorough process.33:52 -- Important take-away from the Trados case: fiduciary duties are owed to the common stockholders.40:00 -- The Basho case (2018),  where a VC investor was ordered to pay ~$20m in damages for using contractual consent rights granted to it as a preferred shareholder together with “hardball” negotiating tactics to force the company to the brink of insolvency and leave it with no choice but to accept “oppressive” financing terms. Inside rounds vs outside rounds.42:27 -- Other thoughts to encourage independent directors in venture-backed companies from Heidi Roizen. "You have to understand the payouts." "As a VC: lead, follow or get out of the way." "We can either be the crusher, or the crushee, but either way something is going to get crashed here." "Sometimes (...) the best thing you can do is say, look, I'll get out of the way.You guys do what you want. We're in the risk business (...) almost half of our deals don't return the capital we put in. And so to be assholes about stuff is a bad idea. You may win the battle, but lose the war, right? You may, you know, twist somebody's arm and get your couple million back, but no entrepreneur is going to want to work with you anymore."49:09 -- On director education for venture-backed companies. New program to launch from UC Law SF and Cooley in San Francisco in March 2024! *For more details: contact Evan Epstein at epsteinevan@uclawsf.edu.51:03 -- Why there are so few independent directors in venture-backed companies? Heidi Roizen: "I think they're undervalued by both investors and entrepreneurs." On board education: Heidi recommends Brad Feld's books, including Venture Deals and Startup Boards. Book mentioned by Evan: Founder vs Investor (by Zalman and Neumann).56:03 -- Heidi's recommendation for independent directors of companies running out of cash: "If the company you're on the board of has only a year or less of runway, you already should be speaking up. If your company has nine months or less of runway, you should already be beginning a process to be sold. And if your company has four months or less of runway, I would resign from that board as an independent. I would speak early, speak often, and if nobody's paying attention to you, I would actually get off that board." "[A]ll the problems happen when you have bad process and when you run out of money."59:06 -- The enhanced role of the board in this downmarket. Heidi: "Structured deals are board for startups."__ You can follow Evan on social media at:Twitter: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__ You can follow Heidi on social media at:Twitter: @HeidiRoizenLinkedIn: https://www.linkedin.com/in/heidiroizen/ The Startup Solution: https://threshold.vc/podcastThreshold VC: https://threshold.vc/__ You can follow SVDX on social media at:Twitter: @svdx1LinkedIn: https://www.linkedin.com/company/silicon-valley-directors'-exchange/Website: https://www.svdx.org/__You can join as a Patron of the Boardroom Governance Podcast at:Patreon: patreon.com/BoardroomGovernancePod__This podcast is sponsored by the American College of Governance Counsel.__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

Host Jim Tate talks to Jay Fisher, a subject matter expert on the MACRA/MIPS program. He provides insights into potential audits, the Cost Category, unintended consequences, and more. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

The Centers for Medicare & Medicaid Services is trying to cut physician Medicare payment yet again. Jennifer Hananoki, JD, assistant director on the AMA Federal Affairs team, joins to address the proposed 2024 Medicare physician pay schedule. She breaks down the 3.36% cut to physician reimbursement, plus what the MIPS scores for 2022 and Oct. 9 deadline to file an appeal mean for physicians. American Medical Association CXO Todd Unger hosts.

The ACO's Emily Levi reports MIPS and MSSP results for our participants and the financial implications.

MIPs and JWR Honda Team Manager Patrik Erlandsson shine a light on how he got into the motocross industry.

Today I am speaking with Pedro Diogo, Senior Technical Program Manager at The Graph Foundation. Pedro has played a pivotal role within The Graph Foundation, collaborating closely with core developers and contributors to bring forth groundbreaking initiatives, including the MIPs program and the recent announcement of the new Chain Integration Process.During our conversation, Pedro offers insights into his background, including an interesting discussion about his home country, Portugal, known for its reputation as one of the friendliest crypto and web3 nations. We then discuss Pedro's journey into the world of crypto, his early engagement with The Graph (as a user!), and his eventual transition into full-time web3 work at The Graph Foundation. At the end, Pedro shares details about recent ecosystem programs he's been involved in and outlines his visionary perspective on the future of The Graph.Show Notes and TranscriptsThe GRTiQ Podcast takes listeners inside web3 and The Graph (GRT) by interviewing members of the ecosystem.  Please help support this project and build the community by subscribing and leaving a review.Twitter: GRT_iQwww.GRTiQ.com

In this episode of the Award-winning PRS Journal Club Podcast, 2023 Resident Ambassadors to the PRS Editorial Board – Rami Kantar, Yoshi Toyoda, and Ronnie Shammas- and special guest Carolyn R. Rogers-Vizena, MD, discuss the following articles from the September 2023 issue: “Plastic Surgeons and Equity: Are Merit-Based Incentive Payment System Scores Impacted by Minority Patient Caseload?” by Byrd, Cichocki, and Chung. Read the article for FREE: https://bit.ly/PSEquityMIPS Special guest Carolyn R. Rogers-Vizena, MD, who is a pediatric/craniofacial surgeon who completed her residency training at the University of Wisconsin, followed by Craniofacial Surgery Fellowship at the Boston Children's Hospital. She is currently an Attending Physician within the Department of Plastic and Oral Surgery at Boston Children's and Assistant Professor at Harvard Medical School who specializes in all areas of pediatric plastic surgery. READ the articles discussed in this podcast as well as free related content from the archives: https://bit.ly/JCSept23Collection #PRSJournalClub

This is a more somber episode. Not the usual, lighthearted faire I've posted previously. Today I'm by myself talking about helmets in an effort to plead with you to check yours. How old is it? Should it be replaced? What's out there now that might be better than what you have? The second part get's a little touchy-feely, so I'll let you know about 10 mins from the end when the helmet part is over. Stay safe out there, and look into a helmet with sphirical MIPS!

The ENRICH trial compared the outcomes between early surgical intervention using the BrainPath® Approach (i.e., MIPS) and a medically managed cohort. The integrated surgical approach included a combination of available technologies, including the FDA-cleared NICO BrainPath® for non-disruptive access and NICO Myriad® to achieve the goal of maximum clot evacuation. Alex Reynolds is joined by the ENRICH trial PIs, Gustavo Pradilla, Jonathan Ratcliff, and Alex Hall plus guests Chris Kellner and Kara Melmed to discuss the findings of the ENRICH clinical trial.  

Mips AB (publ), Q2 2023 Earnings Call, Jul 20, 2023

Sun Ray laptops, MIPS and getting root on them, OpenZFS for HPC Clusters, Self-Hosted Bookmarks using DAV and httpd on OpenBSD, Terraform + Proxmox + OpenBSD =

Today I'm sharing five creative ways to better organize your phone contacts. I hope it's helpful and time-saving toward a very important end: feeling less overwhelmed by relationships!

"It is on us to push this industry forward." - Guy Rocourt"What got us here what got us through a prohibition is what was grown in grandma's garden and made in grandma's kitchen natural simple formulations." - Guy RocourtThis episode of the To Be Blunt podcast features an insightful conversation with Guy Rocourt, co-founder and CEO of Papa and Barkley, a California-based wellness company that believes in the whole plant as medicine and safe access to cannabis. Guy talks about misinformation in the industry, artificial separations foisted on us by prohibition, advocating for cannabis through public speaking, and creating safe access to cannabis products as well as one of the first Class 1 labs in Colorado. His journey through the industry highlights the importance of doing research, speaking truth when entering the cannabis industry, and advocating for responsible adult decision making.[00:00 - 07:35] Shayda Torabi and Guy Rocourt Discuss the Future of Cannabis[07:36 - 14:28] The Story of a Cannabis Advocate's Journey to the Legal Market[14:29 - 21:22] Shame on Misinformation[21:22 - 28:03] Drug Testing and Cannabis[28:03 - 35:57] Uncovering the Misinformation Around CBN[35:58 - 42:48] Understanding the Consumer Journey and Overcoming "Cannabis Shame"[42:49 - 49:31] Navigating California's Cannabis Industry[49:31 - 56:18] Understanding Cannabis, Hemp, and Essential Oils[56:19 - 63:44] "Discover the Benefits of Sun-Grown Cannabis with Papa & Barkley on the To Be Blunt Podcast"[03:09 - 03:44] Stay Connected with To Be Blunt and the Shayda Torabi for Cannabis Conversations!Guy Rocourt is the Co-Founder and Chief Product Officer for Papa & Barkley, a leading California cannabis wellness company. At P&B Guy is responsible for optimizing production practices, ensuring the company complies with rigorous testing and lab standards, and developing the product roadmap as the brand continues to expand into different areas of the cannabis marketplace.Previously Guy designed and built manufactured infused products facilities (MIPs) in multiple states, making him an expert in Cannabis science, tech, strategy, and production. Due to his vast experience he is an asset to those hoping to invest in the space. He also has experience caring for patients with Cannabis. Guy graduated from the Rochester Institute of Technology and is a U.S. Navy veteran.Rocourt uses his keen understanding of the Cannabis plant, Cannabis culture, and business acumen to craft a variety of wellness products and is on a mission like P&B to unlock the power of the plant to improve people's lives. Rocourt is passionate about advocating for Cannabis through public speaking and maintaining an authentic space within Cannabis Culture even as Papa & Barkley continues to grow.Connect with Guy!Go to: https://www.papaandbarkley.com/LinkedInShayda Torabi has been called one of the most influential Women in WordPress and now she's one of the women leading the cannabis reformation conversation building one of Texas' premier CBD brands. She's currently the CEO and Co-Founder of RESTART CBD, a female-run education first CBD wellness brand. And has formerly held marketing positions at WP Engine and WebDevStudios. Shayda is the host of a podcast for cannabis marketers called To Be Blunt, where she interviews top cannabis brands on their most successful marketing initiatives. When Shayda's not building her cannabiz in Texas, you can find her on the road exploring the best hikes and spots for vegan ice cream. Follow Shayda at @theshaydatorabi SPONSORSHIP is brought to you by Restart CBD. Check them out for your CBD needsLEAVE A REVIEW + help someone who wants to join me for episodes featuring some serious cannabis industry by sharing this episode or click here to listen to past episodesRESTART CBD is an education-first CBD wellness brand shipping nationwide.Check out my new website